Nakagawa, T., Matsushima, T., Kawano, S., Nakazawa, Y., Kato, Y., Adachi, Y., . . . Funahashi, Y. (2014). Lenvatinib in combination with golvatinib overcomes hepatocyte growth factor pathway-induced resistance to vascular endothelial growth factor receptor inhibitor. Cancer Sci.
Chicago Style citaatNakagawa, Takayuki, et al. "Lenvatinib in Combination With Golvatinib Overcomes Hepatocyte Growth Factor Pathway-induced Resistance to Vascular Endothelial Growth Factor Receptor Inhibitor." Cancer Sci 2014.
MLA citatieNakagawa, Takayuki, et al. "Lenvatinib in Combination With Golvatinib Overcomes Hepatocyte Growth Factor Pathway-induced Resistance to Vascular Endothelial Growth Factor Receptor Inhibitor." Cancer Sci 2014.
Let op: Deze citaties zijn niet altijd 100% accuraat.